Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Luminal Breast Cancer”

93 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 93 results

Not applicableActive Not RecruitingNCT04370522
What this trial is testing

Characterization of Innate Immune System in Patients With Luminal Advanced Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Spanish Breast Cancer Research Group 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT04759248
What this trial is testing

Study With Atezolizumab in Combination With Trastuzumab and Vinorelbine in HER2-positive Advanced/Metastatic Breast Cancer

Who this might be right for
Breast Cancer
SOLTI Breast Cancer Research Group 55
Not applicableLooking for participantsNCT04133077
What this trial is testing

Xenografts Development From Surgical Tumor Samples of Patients With Triple Negative or Luminal B Breast Cancer

Who this might be right for
Breast Cancer Female
Centre Jean Perrin 85
Not applicableLooking for participantsNCT06261918
What this trial is testing

Transcriptional and Epimetabolic Profile of Breast Carcinoma With Luminal or HER2+ or Locally Advanced Triple-negative Histotype in Patients With/Without Previous Clinical History of Metabolic Syndrome

Who this might be right for
Breast CancerMetabolic Syndrome
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 120
Testing effectiveness (Phase 2)Study completedNCT05520723
What this trial is testing

Preventive stRategy for IMMU132-relatED AEs in TNBC or Luminal Breast Cancer- PRIMED

Who this might be right for
Triple Negative Breast CancerBreast CancerAdvanced HR+/HER2- Breast Cancer
MedSIR 50
Testing effectiveness (Phase 2)Looking for participantsNCT05949541
What this trial is testing

Efficacy of Everolimus Combined With First-line Endocrine Therapy for HR+/HER2- SNF1-subtype Advanced Breast Cancer

Who this might be right for
Breast CancerAdvanced Breast Cancer
Fudan University 265
Testing effectiveness (Phase 2)Study completedNCT03248427
What this trial is testing

Neadjuvant Multi-agent Chemotherapy or Letrozole Plus Ribociclib in Luminal B/HER2-negative Breast Cancer.

Who this might be right for
Breast Cancer
SOLTI Breast Cancer Research Group 106
Not applicableLooking for participantsNCT04469296
What this trial is testing

Diet Modification in pAtients With Luminal Early Breast Cancer Candidate for Primary Surgery

Who this might be right for
Breast CancerSurgery
Institut du Cancer de Montpellier - Val d'Aurelle 75
Not applicableStudy completedNCT04118062
What this trial is testing

Communicating With Patients on Cancer Resistance to Treatment: the Development of a Communication Tool. (HECTOR)

Who this might be right for
Metastatic Uveal MelanomaTriple Negative Breast CancerLuminal B Breast Cancer+1 more
Institut Curie 128
Not applicableActive Not RecruitingNCT03165487
What this trial is testing

Comparison of the Breast Tumor Microenvironment

Who this might be right for
Triple Negative Breast CancerHormone Receptor Positive Malignant Neoplasm of Breast
Columbia University 14
Testing effectiveness (Phase 2)UnknownNCT04023292
What this trial is testing

Comparative Study for the Degree of Biological Changes After Short-term 2 Weeks and 4 Weeks Preoperative Endocrine Therapy in Luminal Breast Cancer

Who this might be right for
Breast Neoplasms
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 185
Testing effectiveness (Phase 2)Study completedNCT01779479
What this trial is testing

Efficacy and Safety of Cabazitaxel Versus Weekly Paclitaxel as Neo-adjuvant Treatment in Patients With Triple Negative or Luminal B/HER2 Normal BC (GENEVIEVE)

Who this might be right for
Primary Breast Cancer
GBG Forschungs GmbH 333
Post-approval studies (Phase 4)UnknownNCT03111615
What this trial is testing

HOrmone Therapy Immediately After Histological Diagnosis of Breast Cancer

Who this might be right for
Hormone Dependent NeoplasmsBreast Cancer Female
Centro Hospitalar Lisboa Ocidental 90
Large-scale testing (Phase 3)Study completedNCT01314833
What this trial is testing

Minus Anthracycline or Short-Term Versus Epirubicin and Cyclophosphamide Followed by Paclitaxel Regimen for Adjuvant Breast Cancer Therapy

Who this might be right for
Primary Breast Cancer
Fudan University 1,570
Testing effectiveness (Phase 2)Ended earlyNCT04714619
What this trial is testing

CB-103 Plus NSAI In Luminal Advanced Breast Cancer

Who this might be right for
Advanced Breast Cancer
MedSIR 2
Testing effectiveness (Phase 2)Active Not RecruitingNCT03875573
What this trial is testing

Neo-adjuvant Chemotherapy Combined With Stereotactic Body Radiotherapy to the Primary Tumour +/- Durvalumab, +/- Oleclumab in Luminal B Breast Cancer:

Who this might be right for
Luminal B
Jules Bordet Institute 147
Testing effectiveness (Phase 2)WithdrawnNCT02140437
What this trial is testing

Fulvestrant Combined Anastrozole Versus Anastrozole in Luminal A-like Postmenopausal ABC

Who this might be right for
Carcinoma Breast Stage IV
Fudan University
Testing effectiveness (Phase 2)Study completedNCT04659551
What this trial is testing

Neoadjuvant Chemo-endocrine Therapy and Immunotherapy for Pre-menopausal Luminal B Breast Cancer Patients

Who this might be right for
Breast Cancer
Istituto Oncologico Veneto IRCCS 43
Not applicableUnknownNCT04137406
What this trial is testing

Role of SIRT1 in Regulation of Epithelial-to-mesenchymal Transition in Breast Cancer Lymph Nodes Metastasis

Who this might be right for
Breast CancerLymph Node Metastases
Peking University People's Hospital 160
Not applicableLooking for participantsNCT07389408
What this trial is testing

A Prospective, Multicenter Registry to Observe the Treatment Patterns, Clinical Outcomes, and Decision-Making in Patients With Early Breast Cancer Eligible for EndoPredict® Testing

Who this might be right for
Breast CancerBreast Adenocarcinoma
National and Kapodistrian University of Athens 2,000
Load More Results